Can cancer therapy be overly targeted?

November 12, 2014

Targeted therapies show limited success with certain cancers


Can cancer therapy be overly targeted?

 

Targeted therapies may hit the bull’s eye of cancer by targeting specific pathways by which it spreads, but a new study published in Nature Genetics in March suggests our optimism about the effectiveness of targeted therapies may be misplaced in the case of certain cancers, such as angiosarcoma (cancer that begins in the blood vessels).

Drugs designed to target specific cellular pathways in this aggressive cancer of the blood vessels have achieved only limited success. Researchers at the Wellcome Sanger Trust Institute have now discovered that this might be due to the fact that there are too many targets for them to deal with. They found that 40 percent of angiosarcoma cases involve mutations in the genes that control blood vessel growth, including two novel cancer genes, PTPRB and PLCG1.

The discovery would usually point to the need for additional treatment targeting those genes as the next step; but the researchers also found multiple mutations in the pathway responsible for blood vessel growth. Drugs designed for singular targets would be ineffective against such multiple mutations.

 

More research needed to combat rare cancers

Angiosarcoma is rare, but survival outcomes for it are poorer than those with other cancer types. Our knowledge of it and relevant treatments are still extremely limited. That makes this research critical as a reassessment of the drugs being used, as well as a guide to developing new ones that will factor in multiple mutations in the cancer’s biology.

In addition, the study has implications for understanding other types of cancer, according to one of the authors of the study quoted in a press release by the institute. “It’s extremely important that we continue to study rare cancers such as angiosarcoma,” says Dr Sam Behjati. “Not only will this help the many patients with these cancers and improve treatment strategies, it will also help us to understand the full landscape of cancer-causing mutations and their underlying biology.”

 

Further links:
Sanger.ac.uk
Nature.com
Bionews-tx.com

Related Articles

“Tidal wave” of cancer predicted

WHO predicts doubling of annual cancer cases by year 2034

Read more

What you need to know about 9 most common cancers

Cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths are caused by cancer.

Read more

What is prostate cancer?

Parkway Cancer Centre’s Dr Zee Ying Kiat gives the low-down on prostate cancer

Read more

Latest Articles

Medical Care

Bladder Cancer: What You Need to Know

Empower yourself with our comprehensive guide to bladder cancer. Explore symptoms, diagnosis, treatments, and supportive resources to safeguard your health.

Read more
Medical Care

Prince Court set to transform brain and spine surgeries with O-Arm Imaging & Navigation System

Revolutionising Brain and Spine Surgery: Prince Court Medical Centre Introduces O-Arm Imaging & Navigation System, Elevating Precision and Patient Outcomes.

Read more
Medical Care

How to Stop Heart Palpitations: 7 Tips and Remedies

Explore effective tips and remedies to prevent heart palpitations. Your comprehensive guide to maintaining a healthy heart rhythm

Read more
Terms & Conditions Privacy Policy
Copyright © 2015 - 2020. All rights reserved.